From BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats:

Jon Stonehouse (image: BioCryst)
Jon Stonehouse (image: BioCryst)

Jon Stonehouse, CEO of BioCryst. Durham, NC-based biotech company working on rare disease drugs.